Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4576525 | 0.90 | ALDH1A1 (0.47) | ALDH1A1PKMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16968209 | 0.87 | ALDH1A1 (0.41) | ALDH1A1PKMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28646842 | 0.86 | ALDH1A1 (0.44) | ALDH1A1PKMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16968228 | 0.85 | CNR1 (0.40) | ALDH1A1PKMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15563858 | 0.85 | PGR (0.40) | ALDH1A1SMN1; SMN2L3MBTL1KMT2A | |
| SCHEMBL12650380 | 0.84 | ALDH1A1 (0.50) | ALDH1A1PKMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL18256164 | 0.84 | ALDH1A1 (0.39) | ALDH1A1PKMNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16968198 | 0.83 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2MAOAMAOBTSHR | |
| SCHEMBL16968258 | 0.83 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1USP2 | |
| SCHEMBL16968208 | 0.83 | SMN1; SMN2 (0.40) | ALDH1A1SMN1; SMN2TSHRMAPK1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9505753-B2 | Inhibitors of D-amino acid oxidase | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-11-29 | — | — | US | disclosed |
| US-20150218156-A1 | INHIBITORS OF D-AMINO ACID OXIDASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-08-06 | — | — | US | disclosed |
| WO-2014025993-A1 | INHIBITORS OF D-AMINO ACID OXIDASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218156-A1 | INHIBITORS OF D-AMINO ACID OXIDASE | DDO, DAO, GRIN2A | ALDH1A1 1465/4885PKM 3088/4885NPC1 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.